特立帕肽
医学
骨质疏松症
合成代谢剂
重症监护医学
合成代谢
临床试验
生物信息学
风险分析(工程)
骨矿物
内科学
生物
作者
Charles Inderjeeth,Diren Che Inderjeeth
标识
DOI:10.1097/med.0000000000000867
摘要
Integrating anabolic agents into personalized treatment plans has the potential to significantly improve outcomes and quality of life for patients with severe osteoporosis, highlighting the importance of this therapeutic class in the management of this chronic condition.
科研通智能强力驱动
Strongly Powered by AbleSci AI